It was shown that the radioresistance of GBM cells depends on the expression level of neuro-glial antigen 2 (NG2/CSPG4), which is the main biomarker of oligodendrocyte progenitor cells (OPCs). The gene discussed is CSPG4; the disease is glioblastoma.